ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT

ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT was reported 28 times

ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PRALATREXATE 1 0.0015
1 BRENTUXIMAB VEDOTIN 15 0.0014
2 HYDROCORTISONE SODIUM SUCCINATE 3 0.0008
3 ROMIDEPSIN 1 0.0006
4 BRIGATINIB 1 0.0003
5 FOSCARNET SODIUM 1 0.0002
6 CRIZOTINIB 3 0.0002
7 DOXORUBICIN HYDROCHLORIDE 7 0.0002
8 DOXORUBICIN 19 0.0002
9 IFOSFAMIDE FOR INJECTION 3 0.0001
10 LORLATINIB 1 0.0001
11 LEUCOVORIN CALCIUM 2 0.0001
12 VINCRISTINE SULFATE 3 0.0001
13 CYTARABINE 6 0.0001
14 BLEOMYCIN SULFATE 1 0.0001
15 DEXAMETHASONE SODIUM PHOSPHATE 1 0.0001
16 ETOPOSIDE 7 0.0001
17 CYCLOPHOSPHAMIDE FOR INJECTION 17 0.0001
18 CYCLOPHOSPHAMIDE 17 0.0001
19 GANCICLOVIR SODIUM 1 0.0001
20 BASILIXIMAB 1 0.0001
21 VALSARTAN AND HYDROCHLOROTHIAZIDE 1 0.0001
22 SIROLIMUS 1 0.0001
23 VALGANCICLOVIR 1 0.0001
24 PREDNISOLONE ORAL SOLUTION 9 0.0000
25 MELPHALAN HYDROCHLORIDE 1 0.0000
26 ERGOCALCIFEROL 1 0.0000
27 FLUDARABINE PHOSPHATE 1 0.0000
28 METHADONE 1 0.0000
29 PREDNISONE 10 0.0000
30 RUXOLITINIB 1 0.0000
31 METHOTREXATE SODIUM 6 0.0000
32 SULFAMETHOXAZOLE AND TRIMETHOPRIM 1 0.0000
33 FISH OIL 1 0.0000
34 LEFLUNOMIDE 1 0.0000
35 TACROLIMUS OINTMENT 0.1% 1 0.0000
36 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
37 CARBOPLATIN 1 0.0000
38 CITALOPRAM 1 0.0000
39 METHYLPREDNISOLONE 1 0.0000
40 TACROLIMUS 1 0.0000
41 INFLIXIMAB 1 0.0000
42 PREGABALIN 1 0.0000
43 DEXAMETHASONE 1.5 MG 1 0.0000
44 DEXAMETHASONE 1 0.0000
45 LEVOTHYROXINE SODIUM 1 0.0000
46 LENALIDOMIDE 1 0.0000
47 OMEPRAZOLE MAGNESIUM 1 0.0000
48 ADALIMUMAB 1 0.0000